Comparative study between sugammadex and neostigmine for the reversal of neuromuscular block in pediatric patients undergoing lower abdominal surgeries.

Trial Profile

Comparative study between sugammadex and neostigmine for the reversal of neuromuscular block in pediatric patients undergoing lower abdominal surgeries.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2017

At a glance

  • Drugs Atropine (Primary) ; Neostigmine (Primary) ; Sugammadex (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2017 Status changed from not yet recruiting to completed, according to results published in the Acta Anaesthesiologica Scandinavica.
    • 10 Feb 2017 Primary endpoint of recovery time has been met, according to results published in the Acta Anaesthesiologica Scandinavica.
    • 10 Feb 2017 Results published in the Acta Anaesthesiologica Scandinavica
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top